From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
The vitamin does not interact with serotonin receptors, dopamine receptors, or other pathways targeted by proven anti-nausea medications
When microdosed, they may help reduce chronic inflammation, enhance metabolic function, and support cardiovascular healthkey factors for aging well and maintaining vitality over time
Physical activity: Engaging in new or strenuous exercise, particularly without proper warm-up or in hot and humid conditions, can cause muscle spasms
If you are using SeekPeptides tracking tools, you can log your injection site along with your dose, timing, and any side effects
3 Frontiers in Pharmacology (2024)NNMT as a candidate therapeutic target for metabolic syndrome (review)
